En Dirgaswara – In a strategic move aimed at safeguarding its interests amidst growing pressure from activist investors, vaccine developer Dynavax proposes the adoption of a shareholder-rights plan, commonly referred to as a “poison pill.” This initiative comes in response to recent developments concerning Deep Track Capital, an investment firm…